Skip to main content
Clinical Trials/JPRN-UMIN000010222
JPRN-UMIN000010222
Recruiting
N/A

The establishment of the effective treatment for hyperuricemia in hypertensive patient with hyperuricemia - The treatment for hyperuricemia

ational Cerebral and Cardiovascular Center0 sites20 target enrollmentMarch 12, 2013
Conditionshyperuricemia

Overview

Phase
N/A
Intervention
Not specified
Conditions
hyperuricemia
Sponsor
ational Cerebral and Cardiovascular Center
Enrollment
20
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 12, 2013
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
ational Cerebral and Cardiovascular Center

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • resistant hypertensive patient (SBP\>\=180mmHg or DBP\>\=110mmHg), heart failure patient (more than NYHA classification III or EF\<\=35%), severe renal damage patient (serum creatinine level \>2 mg/dL), impaired liver function patient (AST or ALT\>\=100IU/ml), the patient with myocardial infarction, angina, and stroke within six months, an acute gouty attack patient, the patient with renal stone, the patient with taking mercaptopurine hydrate, azathioprine or warfarin, the patient with hypersensitivity to benzbromarone or febuxostat, patients to whom the doctor judged the participation in an examination to be unsuitable

Outcomes

Primary Outcomes

Not specified

Similar Trials